Death receptor 5 regulation during selenium-mediated apoptosis in human prostate cancer cells

Cancer Biology and Therapy

Volumn 1, Issue 3, 2002, Pages 287-290

  He, Qin ^a   Rashid, Ayesha ^a   Rong, Rong ^a   Hillman, Michael J ^a   Huang, Ying ^a   Sheikh, M Saeed ^a  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

Caspases; Chemoprevention; Death receptors; Selenium

Indexed keywords

ACYL COENZYME A DESATURASE; ANTIOXIDANT; ARABIDOPSIS PROTEIN; BID PROTEIN, HUMAN; CARRIER PROTEIN; CASP8 PROTEIN, HUMAN; CASP9 PROTEIN, HUMAN; CASPASE; CASPASE 8; CASPASE 9; FAD7 PROTEIN, ARABIDOPSIS; PROTEIN BID; SELENIUM; TNFRSF10A PROTEIN, HUMAN; TNFRSF10B PROTEIN, HUMAN; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR;

APOPTOSIS; ARTICLE; CELL CULTURE; DOMINANT GENE; DRUG EFFECT; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MALE; METABOLISM; MITOCHONDRION; PATHOLOGY; PROSTATE TUMOR; UPREGULATION; WESTERN BLOTTING;

ANTIOXIDANTS; APOPTOSIS; ARABIDOPSIS PROTEINS; BH3 INTERACTING DOMAIN DEATH AGONIST PROTEIN; BLOTTING, WESTERN; CARRIER PROTEINS; CASPASE 8; CASPASE 9; CASPASES; ENZYME ACTIVATION; FATTY ACID DESATURASES; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, DOMINANT; HUMANS; MALE; MITOCHONDRIA; PROSTATIC NEOPLASMS; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; RECEPTORS, TUMOR NECROSIS FACTOR; SELENIUM; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 1242312902     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.83     Document Type: Article

References (29)

1. Parker S, Tong T, Bolden S, Wing PA. Cancer Statistics CA Cancer J Clin 1997; 47:5-27.
2. Ip C. Lessons from basic research in selenium and cancer prevention. J Nutr 1998; 128:1845-54. (Pubitemid 28509845)
3. Menter DG, Sabichi AL, Lippman SM. Selenium effects on prostate cell growth. Cancer Epid Biomarker & Preven 2000; 9:1171-82.
4. Jiang C, Wang Z, Ganther H, Lu J. Caspases as key executors of methyl selenium-induced apoptosis (anoikis) of DU-145 prostate cancer cells. Cancer Res 2001; 61:3062-70. (Pubitemid 32691955)
5. Gross A, McDonnell JM, Korsmeyer SJ. BCL-2 family members and the mitochondria in apoptosis. Genes & Dev 2000; 13:1899-1911.
6. van Bokhoven A, Varella-Garcia M, Korch C, Miller GJ. TSU-Pr1 and JCA-1 cells are derivatives of T24 bladder carcinoma cells and are not of prostatic origin. Cancer Res. 2001; 61:6340-4. (Pubitemid 32783234)
7. Huang Y, He Q, Hillman MJ, Rong R, Sheikh MS. Sunlindac sulfide-induced apoptosis involves death receptor 5 and the caspase 8-dependent pathway in human colon and prostate cancer cells. Cancer Res 2001; 61:6918-24. (Pubitemid 32896519)
8. Sheikh MS, Burns TF, Huang Y, Wu GS, Amundson S, Brooks KS, et al. p53-dependent and independent regulation of the death receptor KILLER/DR5 gene expression in response to genotoxic stress and TNFα. Cancer Res 1998; 58:1593-8. (Pubitemid 28215076)
9. Our unpublished results.
10. Sheikh MS, Li XS, Chen JC, Shao ZM, Ordonez JV, Fontana JA. Mechanisms of regulation of WAF1/Cip1 gene expression in human breast carcinoma: role of p53-dependent and independent signal transduction pathways. Oncogene. 1994; 9:3407-15.
11. Gewies A, Rokhlin OW, Cohen MB. Cytochrome c is involved in Fas-mediated apoptosis of prostatic carcinoma cell lines. Cancer Res 2000; 60:2163-8. (Pubitemid 30225179)
12. Hassan SB, Jonsson E, Larsson R, Karlsson MO. Model for Time Dependency of Cytotoxic Effect of CHS 828 in Vitro Suggests Two Different Mechanisms of Action. J Pharmacol Exp Ther 2001; 299:1140-7. (Pubitemid 33104987)
13. Ashkenazi A, Dixit VM. Apoptosis control by death and decoy receptors. Curr Opin Cell Biol 1999; 11:255-60. (Pubitemid 29164042)
14. Nimmanapalli R, Perkins CL, Orlando M, O'Bryan E, Nguyen D, Bhalla KN. Pretreatment with paclitaxel enhances apo-2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of prostate cancer cells by inducing death receptors 4 and 5 protein levels. Cancer Res 2001; 61:759-63. (Pubitemid 32128643)
15. Li H, Zhu H, Xu CJ, Yuan J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 1998; 94:491-501. (Pubitemid 28391865)
16. Chou JJ, Li H, Salvesen GS, Yuan J, Wagner G. Solution structure of BID, an intracellular amplifier of apoptotic signaling. Cell 1999; 96:615-24. (Pubitemid 29122804)
17. Korsmeyer SJ, Wei MC, Saito M, Weiler S, Oh KJ, Schlesinger PH. Pro-apoptotic cascade activates BID, which oligomerizes BAK or BAX into pores that result in the release of cytochrome c. Cell Death Differ 2000; 7:1166-73. (Pubitemid 32042223)
18. Chaudhary PM, Eby M, Jasmin A, Bookwalter A, Murray J, Hood L. Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-kappa B pathway. Immunity 1997; 7:821-30. (Pubitemid 28064895)
19. Schnieder P, Thome M, Burns K, Bodmer JL, Hofman K, Kataoka T, et al. TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappa B. Immunity 1997; 7:831-6. (Pubitemid 28064896)
20. Sprick MR, Weigand MA, Rieser E, Rauch CT, Juo P, Blenis J, et al. FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2. Immunity 2000; 12:599-609.
21. Kischkel FC, Lawrence DA, Chuntharapai A, Schow P, Kim KJ, Ashkenazi A. Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5. Immunity 2000; 12:611-20.
22. Kuang AA, Diehl GE, Zhang J, Winoto A. FADD is required for DR4- and DR5-mediated apoptosis: lack of trail-induced apoptosis in FADD-deficient mouse embryonic fibroblasts. J Biol Chem 2000; 275:25065-8.
23. Morgan MJ, Thorburn J, Thomas L, Maxwell T, Brothman AR, Thorburn A. An apoptosis signaling pathway induced by the death domain of FADD selectively kills normal but not cancerous prostate epithelial cells. Cell Death Differ 2001; 8:696-705. (Pubitemid 32685167)
24. Fujiwara N, Fujii T, Fujii J, Tanaguchi N. Functional expression of rat thioredoxin redutase: selenocysteine insertion sequence element is essential for the active enzyme. Biochem J 1999; 340:439-44. (Pubitemid 29286564)
25. Wingler K, Bocher M, Flohe L, Kollmus H, Brigelius-Flohe R. mRNA stability and selenocysteine insertion sequence efficiency rank gastrointestinal glutathione peroxidase high in the hierarchy of selenoproteins. Eur J Biochem 1999; 259:149-57. (Pubitemid 29030830)
26. Shen HM, Yang CF, Ong CN. Sodium selenite-induced oxidative stress and apoptosis in human hepatoma HepG2 cells. Int J Cancer 1999; 81:820-8.
27. Yan L, Spalholz JE. Generation of reactive oxygen species from the reaction of selenium compounds with thiols and mammary tumor cells. Biochem Pharmacol 1993; 45:429-37. (Pubitemid 23042643)
28. Gasdaska PY, Berggren MM, Bery MJ, Powis G. Cloning, sequencing and functional expression of a novel human thioredoxin reductase. FEBS Lett 1999; 442:105-11. (Pubitemid 29065388)
29. Ganther HE. Selenium metabolism, selenoproteins and mechanisms of cancer prevention: complexities with thioredoxin reductase. Carcinogenesis (Lond.) 1999; 20:1657-66. (Pubitemid 29410542)